(Q43990916)

28 November 2017

Carbamazepine augmentation in depressive patients non-responding to citalopram: a pharmacokinetic and clinical pilot study (English)

1 reference

28 November 2017

1 reference

1 reference

Chin B Eap

4

0 references

author name string

Lina Steinacher

1

1 reference

28 November 2017

Pierre Vandel

2

1 reference

28 November 2017

Daniele F Zullino

3

1 reference

28 November 2017

Marlyse Brawand-Amey

5

1 reference

28 November 2017

Pierre Baumann

6

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

European Neuropsychopharmacology

28 November 2017

1 reference

28 November 2017

12

1 reference

28 November 2017

255-260

1 reference

28 November 2017

3

1 reference

A double-blind, placebo-controlled study of citalopram with and without lithium in the treatment of therapy-resistant depressive patients: a clinical, pharmacokinetic, and pharmacogenetic investigation

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

Enantiomeric antidepressant drugs should be considered on individual merit

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

Clinical pharmacokinetics and pharmacological effects of carbamazepine and carbamazepine-10,11-epoxide. An update

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

Carbamazepine treatment induces the CYP3A4 catalysed sulphoxidation of omeprazole, but has no or less effect on hydroxylation via CYP2C19.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

Concomitant intake of nortriptyline and carbamazepine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

Carbamazepine-induced release of serotonin from rat hippocampus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

Carbamazepine addition in tricyclic antidepressant-resistant unipolar depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

Lithium addition in treatment-resistant depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

Effects of Carbamazepine Coadministration on Plasma Concentrations of the Enantiomers of Mianserin and of its Metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

Antiepileptic drug augmentation for treatment-resistant depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

The serotonin syndrome scale: first results on validity.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

The pharmacological effect of citalopram residues in the (S)-(+)-enantiomer

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

Fluvoxamine Inhibition and Carbamazepine Induction of the Metabolism of Clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

1 reference

7 January 2021

Refractory depression: a review with particular reference to the use of lithium augmentation

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

Lack of sertraline efficacy probably due to an interaction with carbamazepine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

Analysis of the enantiomers of citalopram and its demethylated metabolites using chiral liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

In vitro biotransformation of the selective serotonin reuptake inhibitor citalopram, its enantiomers and demethylated metabolites by monoamine oxidase in rat and human brain preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

Autoinduction and steady-state pharmacokinetics of carbamazepine and its major metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

Carbamazepine-nefazodone interaction in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

Substituting carbamazepine with oxcarbazepine increases citalopram levels. A report on two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

Olanzapine serum concentrations lowered by concomitant treatment with carbamazepine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

A pharmacokinetic interaction between carbamazepine and olanzapine: observations on possible mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

An interaction between carbamazepine and fluvoxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

Montgomery-Asberg severity gradations

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

Lack of effect of citalopram on the steady-state pharmacokinetics of carbamazepine in healthy male subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

Escitalopram (S-enantiomer of citalopram): clinical efficacy and onset of action predicted from a rat model

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

Biphasic effects of carbamazepine on the dopaminergic system in rat striatum and hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

Studies on the Stereoselective Metabolism of Citalopram by Human Liver Microsomes and cDNA-Expressed Cytochrome P450 Enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

Citalopram: a comprehensive review

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

Is therapeutic drug monitoring a case for optimizing clinical outcome and avoiding interactions of the selective serotonin reuptake inhibitors?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

Identification of three cytochrome P450 isozymes involved in N-demethylation of citalopram enantiomers in human liver microsomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

Stereoselective biotransformation of the selective serotonin reuptake inhibitor citalopram and its demethylated metabolites by monoamine oxidases in human liver

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

Pharmacokinetics of citalopram in relation to the sparteine and the mephenytoin oxidation polymorphisms

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

The effect of carbamazepine on the 2-hydroxylation of desipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

Plasma concentrations of risperidone and 9-hydroxyrisperidone: effect of comedication with carbamazepine or valproate

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

Carbamazepine coadministration with fluoxetine or fluvoxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

Clinically significant pharmacokinetic drug interactions with carbamazepine. An update

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

1 reference

7 January 2021

The effect of citalopram in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

Lithium augmentation in depressive patients not responding to selective serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900018-4

7 January 2021

10.1016/S0924-977X(02)00018-4

Identifiers

DOI

1 reference

28 November 2017

1 reference